Total Funding
28
59
Total FundingPost-IPO Equity raised
Growth Score 28 in past quarter
-5 pts
Heat Score 59 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
239799
ANGECON is a biotechnology company that develops cell drugs and healthy cell storage.
- Jin Yiqiang: Founder & CEO
About the Company
ANGECON performs cell development, manufacturing, sales, warehousing, and service. They create new cell medicines and offer a variety of cell treatments to people suffering from long-term conditions of the central nervous system. They have established a base for cell production demonstration using their cell technologies, including cell separation
and purification, culture and expansion, cryopreservation and recovery, directional induction, identification, and testing.